International Forum on GMP‐grade human platelet lysate for cell propagation: summary
Authors:
- D. StrunkDSD. Strunk
- M. LozanoMLM. Lozano
- D.C. MarksDMD.C. Marks
- Y. S. LohYLY. S. Loh
- G. GstraunthalerGGG. Gstraunthaler
- H. SchennachHSH. Schennach
- E. RohdeERE. Rohde
- S. Laner‐PlambergerSLS. Laner‐Plamberger
- M. ÖllerMÖM. Öller
- J. NystedtJNJ. Nystedt
- R. LotfiRLR. Lotfi
- M. RojewskiMRM. Rojewski
- 26 October 2017
- journal article
- editorial
- Published by Wiley in Vox Sanguinis
- Vol. 113 (1) , 80-87
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Clarifying Stem-Cell Therapy’s Benefits and RisksNew England Journal of Medicine, 2017
- Platelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem/stromal cells: present and futureStem Cell Research & Therapy, 2016
- Current perspectives on the use of ancillary materials for the manufacture of cellular therapiesCytotherapy, 2016
- Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation?Biomaterials, 2016
- Platelet Lysate as Replacement for Fetal Bovine Serum in Mesenchymal Stromal Cell CulturesTransfusion Medicine and Hemotherapy, 2013
- Human Alternatives to Fetal Bovine Serum for the Expansion of Mesenchymal Stromal Cells from Bone MarrowStem Cells, 2009
- Human platelet lysate can replace fetal bovine serum for clinical‐scale expansion of functional mesenchymal stromal cellsTransfusion, 2007
- Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applicationsJournal of Cellular Physiology, 2005